Biotech advances fuel demand for genomics software
WHEN Qiagen scooped up Redwood City, California-based Ingenuity Systems this year, the acquisition marked the first time the biotechnology giant had purchased a firm that exclusively makes software.
The purchase allows Qiagen to analyse information it derives from the genetic maps of organisms, which can be used to detect variations and mutations that point to the cause of certain diseases or new ways to treat them.
The deal is indicative of the increasing interdependency of the life sciences and information technology industries.
The cost of determining an organism's genetic makeup has fallen considerably since the first human genome was mapped more than a decade ago - so much so that scientists and physicians envision a future in which DNA mapping will be standard medical practice.